New hope for anxiety patients who Don't get better on current drugs

NCT ID NCT06701903

Summary

This study is testing whether a new medication called ITI-1284 can help adults with moderate to severe generalized anxiety disorder (GAD) who haven't gotten enough relief from at least two standard anxiety treatments. About 570 participants will be randomly assigned to receive either one of two doses of ITI-1284 or a placebo pill for six weeks, in addition to their current care. The main goal is to see if the new drug safely reduces anxiety symptoms more effectively than a placebo.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENERALIZED ANXIETY DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cinical Site

    ACTIVE_NOT_RECRUITING

    Orlando, Florida, 32803, United States

  • Clinical Site

    RECRUITING

    Birmingham, Alabama, 35294, United States

  • Clinical Site

    RECRUITING

    Little Rock, Arkansas, 72211, United States

  • Clinical Site

    RECRUITING

    Rogers, Arkansas, 72758, United States

  • Clinical Site

    RECRUITING

    Culver City, California, 90230, United States

  • Clinical Site

    RECRUITING

    Encino, California, 91316, United States

  • Clinical Site

    RECRUITING

    Los Angeles, California, 90025, United States

  • Clinical Site

    RECRUITING

    Oceanside, California, 92056, United States

  • Clinical Site

    RECRUITING

    Sherman Oaks, California, 91403, United States

  • Clinical Site

    ACTIVE_NOT_RECRUITING

    Upland, California, 91786, United States

  • Clinical Site

    RECRUITING

    Walnut Creek, California, 94596, United States

  • Clinical Site

    RECRUITING

    Farmington, Connecticut, 06030, United States

  • Clinical Site

    ACTIVE_NOT_RECRUITING

    Gainesville, Florida, 32607, United States

  • Clinical Site

    RECRUITING

    Miami, Florida, 33176, United States

  • Clinical Site

    NOT_YET_RECRUITING

    Tampa, Florida, 33612, United States

  • Clinical Site

    NOT_YET_RECRUITING

    Tampa, Florida, 33613, United States

  • Clinical Site

    RECRUITING

    Decatur, Georgia, 30030, United States

  • Clinical Site

    NOT_YET_RECRUITING

    Chicago, Illinois, 60611, United States

  • Clinical Site

    ACTIVE_NOT_RECRUITING

    Boston, Massachusetts, 02131, United States

  • Clinical Site

    RECRUITING

    Flowood, Mississippi, 39232, United States

  • Clinical Site

    RECRUITING

    Brooklyn, New York, 11235, United States

  • Clinical Site

    ACTIVE_NOT_RECRUITING

    Buffalo, New York, 14215, United States

  • Clinical Site

    RECRUITING

    Staten Island, New York, 10314, United States

  • Clinical Site

    NOT_YET_RECRUITING

    Columbus, Ohio, 43210, United States

  • Clinical Site

    RECRUITING

    Oklahoma City, Oklahoma, 73116, United States

  • Clinical Site

    RECRUITING

    Media, Pennsylvania, 19063, United States

  • Clinical Site

    NOT_YET_RECRUITING

    Dallas, Texas, 75231, United States

  • Clinical Site

    RECRUITING

    Dallas, Texas, 75243, United States

  • Clinical Site

    RECRUITING

    Bellevue, Washington, 98007, United States

  • Clinical Site

    RECRUITING

    Blagoevgrad, 2700, Bulgaria

  • Clinical Site

    RECRUITING

    Kardzhali, 6600, Bulgaria

  • Clinical Site

    RECRUITING

    Pleven, 5800, Bulgaria

  • Clinical Site

    RECRUITING

    Plovdiv, 4004, Bulgaria

  • Clinical Site

    RECRUITING

    Rousse, 7003, Bulgaria

  • Clinical Site

    RECRUITING

    Sofia, 1408, Bulgaria

  • Clinical Site

    RECRUITING

    Sofia, 1510, Bulgaria

  • Clinical Site

    RECRUITING

    Sofia, 1680, Bulgaria

  • Clinical Site

    RECRUITING

    Targovishte, 7700, Bulgaria

  • Clinical Site

    NOT_YET_RECRUITING

    Helsinki, 00100, Finland

  • Clinical Site

    NOT_YET_RECRUITING

    Kuopio, 70110, Finland

  • Clinical Site

    NOT_YET_RECRUITING

    Oulu, 90100, Finland

  • Clinical Site

    NOT_YET_RECRUITING

    Tampere, 33210, Finland

  • Clinical Site

    RECRUITING

    Bialystok, 15272, Poland

  • Clinical Site

    RECRUITING

    Bydgoszcz, 85-080, Poland

  • Clinical Site

    RECRUITING

    Gdansk, 80283, Poland

  • Clinical Site

    RECRUITING

    Leszno, 64100, Poland

  • Clinical Site

    RECRUITING

    Torun, 87100, Poland

  • Clinical Site

    RECRUITING

    Belgrade, 11000, Serbia

  • Clinical Site

    RECRUITING

    Kovin, 26220, Serbia

  • Clinical Site

    RECRUITING

    Kragujevac, 34000, Serbia

  • Clinical Site

    RECRUITING

    Niš, 18000, Serbia

  • Clinical Site

    RECRUITING

    Novi Kneževac, 23330, Serbia

  • Clinical Site

    RECRUITING

    Bratislava, 82101, Slovakia

  • Clinical Site

    RECRUITING

    Rimavská Sobota, 97901, Slovakia

  • Clinical Site

    RECRUITING

    Svidník, 08901, Slovakia

  • Clinical Site

    RECRUITING

    Vranov nad Topľou, 09301, Slovakia

  • Clinical Site_2

    RECRUITING

    Encino, California, 91316, United States

  • Clinical Site_2

    RECRUITING

    Belgrade, 11000, Serbia

  • Clinical Site_3

    RECRUITING

    Belgrade, 11000, Serbia

  • Clinical Site_4

    RECRUITING

    Belgrade, 11000, Serbia

Conditions

Explore the condition pages connected to this study.